Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-Administration of MK0431 and Metformin in T2DM
NCT00103857Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2005
- Primary completion
- Jul 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Mar 2005; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00103857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103857.